PPT-1 New Devices in Diabetes Care

Have you ridden a bicycle in the last month 1 Yes 2 No Ebike LifeBikecom 2 Developed by a sports physician It is a pedal assisted bike not a scooter Made for people who have a fear of falling can manage a rider up to 400 pounds balanced for ease of getting on and off plus absorbs shocks better then most bicycles and controls made for a person with arthritis. DCE is comprised of members of the Academy of Nutrition and Dietetics who are leaders in the field of medical nutrition therapy and care of people with diabetes Their expertise is widely recognized throughout the diabetes community We are pleased to Neda. . Ratanawongsa. , MD, MPH. September 20, 2011. 2. Disclosures. Projects funded by:. AHRQ 5R21HS014864. AHRQ 5R18HS017261. McKesson Foundation. CDC Division of Diabetes Translation grant. California Diabetes Program. .. Label each individual piece of equipment with the resident’s name to prevent inappropriate use.. Virginia Department of Health. Division of Surveillance and Investigation. Healthcare-Associated Infections Program. Efficacy and Safety of Antihyperglycemic Therapies Introduced Since 2004. 1. DPP-4 Inhibitors. 2. FDA-Approved Agents. Alogliptin. Linagliptin. Saxagliptin. Sitagliptin. Key Features. Oral administration. Disclosure. Robert Ratner has no disclosures.. Process. ADA’s Professional Practice Committee (PPC) conducts annual review & revision.. Searched Medline for human studies related to each subsection and published since January 1, 2015.. Efficacy and Safety of Modern Antihyperglycemic Therapies. 1. DPP-4 Inhibitors. 2. DPP-4 Inhibitors. FDA-Approved . Agents. Alogliptin. Linagliptin. Saxagliptin. Sitagliptin. Key . Features. Oral administration. Number of deaths attributable to high blood glucose males females ages 30–69 630 ages 30–69 1 160 ages 70+ 340 ages 70+ 1 100 Operational policy/strategy/action plan for diabetes Evidence-based na global medical supplies market was worth USD 118.3 billion in the year 2020 and is further projected to reach USD 154.0 billion by 2027, growing at the CAGR of 3.8% in the forecast period (2021-2027) The global diabetes care devices market was worth USD 8.9 billion in 2020 and is further projected to reach USD 14.0 billion by the year 2027, growing at the CAGR of 6.7% in the forecast period (2021-2027) the time of COVID- 19 . Professor . Vinod. Patel. FHEA FRCP MD MRCGP DRCOG . PSc. Professor, Diabetes and Clinical Skills. Hon Consultant in Endocrinology and Diabetes. Warwick Medical School, George Eliot Hospital NHS Trust, Nuneaton. Presented by Katie Spear MSN, RN,CDCES. 3 Take away Points. You have to learn how to take care of yourself.. Get all of the information that you can to help you stay healthy.. Make the time for your self-care.. Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP. Endocrine Clinical Pharmacy Specialist. CGM and Remote Monitoring Program Coordinator. Cleveland Clinic Endocrinology and Metabolist Institute. in YOUR Practice . . Katie Murphy. Diabetes Nurse . Facillitator. Diabetes In General Practice (DiGP). Where to start!. Register- How many patients require care. Quantifying the time required- 2 -3 visits per year. .. Label each individual piece of equipment with the resident’s name to prevent inappropriate use.. Virginia Department of Health. Division of Surveillance and Investigation. Healthcare-Associated Infections Program.